SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

DelMar Pharmaceuticals Q3 EPS $(0.170) Up From $(0.670) YoY

DelMar Pharmaceuticals (NASDAQ:DMPI) reported quarterly losses of $(0.170) per share. This is a 74.63 percent increase over losses of $(0.670) per share from the same period last year.

Benzinga · 05/13/2020 12:03

DelMar Pharmaceuticals (NASDAQ:DMPI) reported quarterly losses of $(0.170) per share. This is a 74.63 percent increase over losses of $(0.670) per share from the same period last year.